Brand Name(s): Furadantin, Macrobid, Macrodantin
CAS nº: 67-20-9
(nye troe fyoor an’ toyn)

About Nitrofurantoin

This new site is dedicated exclusively to nitrofurantoin.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about nitrofurantoin, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total nitrofurantoin experience! 

Why is this medication prescribed?

Nitrofurantoin is an anti-bacterial that is used to treat urinary tract infections caused by many gram-negative and some gram-positive bacteria.

This medication works by interfering with the bacterial metabolism of carbohydrate and also disrupting the formation of the bacterial cell wall.

Three forms are available: a microcrystalline form (Furadantin®), a macrocrystalline form (Macrodantin®), and a sustained release macrocrystalline form used twice daily (Macrobid®). The macrocrystalline form is more slowly absorbed than the microcrystalline version and is useful for patients who have difficulty tolerating this second type of medication.

See more Product Info

Latest News

Uncomplicated urinary tract infection in women

Acute uncomplicated urinary tract infections (uUTIs) occur in non-pregnant women with normal...

[more]

Generic drug maker fails in effort against Procter

A company that sells a generic version of a drug made by Procter & Gamble Co. lost its appeal to...

[more]

Consider nitrofurantoin in bacterial-resistance era

Nitrofurantoin should be considered as a fluoroquinolone-sparing agent for women with mild to...

[more]

Eon Labs (ELAB) Receives Final Approval For Nitrofurantoin Monohydrate/Macrocrystals Capsules

Eon Labs (ELAB) Receives Final Approval For Bupropion HCl, ER 200mg Tablets And Will Begin Shipping...

[more]

Ranbaxy Receives FDA Approval To Market A Generic Alternative To Macrobid®

Ranbaxy Laboratories Limited (RLL) announced today that the Company has received approval from the...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.